EVALUATION OF PNEUMOCOCCAL TITERS AND RESPONSE TO 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE IN CHILDREN WITH COUGH

被引：0
|
作者：
Anthony, K. [1 ]
Urrego, F. [2 ]
机构：
[1] Tulane Univ, Ochsner Childrens Hlth Ctr, New Orleans, LA 70118 USA
[2] Ochsner Childrens Hlth Ctr, New Orleans, LA USA
来源：
PEDIATRIC PULMONOLOGY | 2014年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
43
引用
收藏
页码：S78 / S78
页数：1
相关论文
共 50 条
  • [41] Recommendations for the use of the 23-valent polysaccharide pneumococcal vaccine in adults: A Belgian consensus report
    Peetermans, WE
    Van de Vyver, N
    Van Laethem, Y
    Van Damme, P
    Thiry, N
    Trefois, P
    Geerts, P
    Schetgen, M
    Peleman, R
    Swennen, B
    Verhaegen, J
    ACTA CLINICA BELGICA, 2005, 60 (06) : 329 - 337
  • [42] Safety and immunogenicity of a single dose 23-valent pneumococcal polysaccharide vaccine in Russian subjects
    Ciprero, Karen
    Zykov, Kirill A.
    Briko, Nikolay I.
    Shekar, Tulin
    Sterling, Tina M.
    Bitieva, Elizaveta
    Stek, Jon E.
    Musey, Luwy
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (08) : 2142 - 2147
  • [43] Analysis of Vaccination Rates of 23-Valent Pneumococcal Polysaccharide Vaccine in Hospitalized Patients with Diabetes
    Seagroves, Amy
    Reh, Christina S.
    Bischoff, Nathaniel
    Nally, Laura M.
    Singh, Jasjit
    DIABETES, 2017, 66 : A377 - A378
  • [44] Skin necrosis following 23-valent pneumococcal polysaccharide vaccination
    Thompson, Deborah L.
    Dores, Graca M.
    Ahluwalia, Jaspal
    Arya, Deepa P.
    Niu, Manette
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 450 - 450
  • [45] CLINICAL EFFICACY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Tarasova, G.
    Belov, B.
    Egorova, O.
    Reshetnyak, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1369 - 1370
  • [46] Effectiveness and practical uses of 23-valent pneumococcal polysaccharide vaccine in healthy and special populations
    Wang, Yang
    Li, Jingxin
    Wang, Yuxiao
    Gu, Wei
    Zhu, Fengcai
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (04) : 1003 - 1012
  • [47] Effectiveness of the 23-valent polysaccharide vaccine against invasive pneumococcal disease in Navajo adults
    Benin, AL
    O'Brien, KL
    Watt, JP
    Reid, R
    Zell, ER
    Katz, S
    Donaldson, C
    Parkinson, A
    Schuchat, A
    Santosham, M
    Whitney, CG
    JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (01): : 81 - 89
  • [48] Revaccination of adults with spinal cord injury using the 23-valent pneumococcal polysaccharide vaccine
    Waites, Ken B.
    Canupp, Kay C.
    Chen, Yu-ying
    DeVivo, Michael J.
    Nahm, Moon H.
    JOURNAL OF SPINAL CORD MEDICINE, 2008, 31 (01): : 53 - 59
  • [49] No preventive effects of 23-valent pneumococcal polysaccharide vaccine in patients with chronic renal failure
    Hsieh, Meng-Jer
    Yu, Chun-Chen
    Hu, Han-Chung
    Thai, Ying-Huang
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [50] Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults 60-64 years of age
    Greenberg, Richard N.
    Gurtman, Alejandra
    Frenck, Robert W.
    Strout, Cynthia
    Jansen, Kathrin U.
    Trammel, James
    Scott, Daniel A.
    Emini, Emilio A.
    Gruber, William C.
    Schmoele-Thoma, Beate
    VACCINE, 2014, 32 (20) : 2364 - 2374
12345